Cumberland Pharmaceuticals Inc. Company Profile
NASDAQ: CPIXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Cumberland Pharmaceuticals at a glance
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Nashville, TN. Cumberland Pharmaceuticals is led by Mr. A. J. Kazimi MBA and employs about 88 people. The company's shares have traded publicly since 2009.
At a market capitalization of $87.6 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001087294, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Cumberland Pharmaceuticals do?
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea and vomiting in patients receiving chemotherapy treatment; Vaprisol, an injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Vibativ, an injection for the treatment of certain bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections; and Tacilia, an oral capsule for the treatment of H. pylori infection. It also develops ifetroban, a product candidate that has completed Phase II clinical trials for the treatment of cardiomyopathy associated with Duchenne muscular dystrophy, hepatorenal syndrome, portal hypertension, aspirin-exacerbated respiratory disease, systemic sclerosis, and idiopathic pulmonary fibrosis. It serves hospital acute care, gastroenterology, and oncology markets in the United States, China, South Korea, Russia, Mexico, Australia, and Saudi Arabia. The company has a strategic alliance agreement with WinHealth Pharma Group Co. Limited. Cumberland Pharmaceuticals Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.
Business description based on the company's public filings.
Company information
- Legal name
- Cumberland Pharmaceuticals Inc.
- Ticker
- NASDAQ: CPIX
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. A. J. Kazimi MBA
- Employees
- 88
- Headquarters
- 1600 West End Avenue, Nashville, TN, United States
- Phone
- 615 255 0068
- Website
- cumberlandpharma.com
- IPO year
- 2009
- Market cap
- $87.57M
- SEC CIK
- 0001087294
- Latest annual report
- 10-K · Mar 9, 2026
Companies similar to Cumberland Pharmaceuticals
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| RTSNRetension Pharmaceuticals Inc. | 10.51 | -19.22% | $87.57M | vs CPIX |
| EQEquillium Inc. | 1.06 | -5.36% | $87.26M | vs CPIX |
| UPBUpstream Bio Inc. | 1.59 | -20.50% | $87.15M | vs CPIX |
| ANIXAnixa Biosciences Inc. | 2.44 | -6.15% | $84.82M | vs CPIX |
| NTHINeOnc Technologies Holdings Inc. | 3.15 | -9.48% | $90.88M | vs CPIX |
| CATXPerspective Therapeutics Inc. | 0.7538 | -3.85% | $91.03M | vs CPIX |
| CLLSCellectis S.A. ADR | 0.9209 | -7.89% | $92.76M | vs CPIX |
| OGIOrganigram Global Inc. | 0.583 | -7.40% | $82.27M | vs CPIX |